Keyphrases
PET-MRI
100%
Magnetic Resonance Imaging
54%
Positron Emission Tomography
53%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
47%
HyperPET
47%
Hyperpolarized
45%
Positron Emission Tomography-computed Tomography (PET-CT)
42%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
35%
Electrochemotherapy
33%
Lactate
28%
18F-fluorodeoxyglucose (18F-FDG)
27%
Tumor
27%
FDG Uptake
26%
Cancer Patients
26%
13C Pyruvate
26%
MRI Scan
25%
Canine Cancer
23%
Diffusion Magnetic Resonance Imaging (dMRI)
23%
MR Spectroscopic Imaging (MRSI)
22%
Warburg Effect
21%
Early Response
20%
Magnetic Resonance Spectroscopy
20%
Apparent Diffusion Coefficient
19%
In Cancer
18%
MR Scanners
17%
Multiparametric Imaging
16%
Head-and-neck Cancer
15%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
15%
Tumor Volume
14%
Phase I Study
14%
Phase II Clinical Trial
14%
Clinical PET
14%
Hyperpolarized 13C
14%
Gallium-68
13%
Response Evaluation Criteria in Solid Tumors (RECIST)
13%
Computed Tomography
13%
Radiotherapy
13%
Response Evaluation
13%
Acute Stroke
13%
Lung Cancer
13%
NODAGA
13%
Magnetic Resonance Imaging Techniques
13%
Angiogenesis
13%
Colorectal Cancer
13%
Tumor Heterogeneity
13%
Neuroendocrine Neoplasms
13%
Breast Cancer Recurrence
13%
Phase Contrast
13%
Irinotecan
13%
Metastatic Colorectal Cancer (mCRC)
13%
Medicine and Dentistry
Positron Emission Tomography
84%
Magnetic Resonance Imaging
81%
Positron Emission Tomography
66%
Positron Emission Tomography - Magnetic Resonance Imaging
59%
Positron Emission Tomography-Computed Tomography
50%
Pyruvic Acid
44%
Neoplasm
42%
Fluorodeoxyglucose F 18
36%
Electrochemotherapy
33%
Malignant Neoplasm
33%
Carbon 13
32%
Fluorine-18
30%
Head and Neck Squamous Cell Carcinoma
26%
Lactic Acid
22%
Biological Marker
20%
Tattoo
20%
Copper 64
20%
Recurrent Disease
19%
Warburg Effect
16%
Clinical Trial
16%
Radiation Therapy
16%
Biopsy
16%
Magnetic Resonance Spectroscopic Imaging
15%
Diffusion MRI
15%
Head and Neck Cancer
14%
Neuroendocrine Tumor
14%
Disease
14%
Gallium 68
13%
Breast Cancer
13%
Electroporation
13%
Nuclear Magnetic Resonance Spectroscopy
13%
Deoxyglucose
13%
Angiogenesis
13%
Clinical Study
13%
Adenocarcinoma
13%
Standardized Uptake Value
12%
Computer Assisted Tomography
12%
Chemoradiotherapy
12%
Treatment Response
11%
Adverse Event
11%
Metabolism
11%
Atherosclerosis
10%
General Anesthesia
9%
Prostate Cancer
8%
Squamous Cell Carcinoma
8%
Phenotype
8%
Functional Imaging
8%
Edema
8%
Histopathology
8%
Infection
8%